Mount Sinai Health System · 3 months ago
Postdoctoral Fellow-MSH-30030-274
Mount Sinai Health System is a leading academic medical institution dedicated to transforming healthcare. They are seeking a highly motivated Postdoctoral Fellow to investigate virus–host interactions with a focus on airway biology and antiviral defense, offering an opportunity to work in a collaborative and well-resourced environment.
Health CareHospitalMedical
Responsibilities
Lead independent and collaborative projects on respiratory virus–host mechanisms
Apply molecular virology, advanced cell culture systems (ALI and iPSC-derived models), microscopy, proteomics, and in vivo mouse models
Analyze data, write manuscripts, and present at lab meetings and conferences
Help mentor students and contribute to a supportive lab culture
Qualification
Required
Ph.D. (or equivalent) in Virology, Immunology, Molecular/Cell Biology, or a related field
Strong foundation in molecular virology, cell biology, or immunology
Excellent communication skills; self-driven; team-oriented
Preferred
Preferred experience in one or more: respiratory viruses; cilia/airway epithelial models; microscopy; mouse models of infection
Benefits
Access to world-class core facilities at Mount Sinai.
A dynamic, international environment within the Global Health & Emerging Pathogens Institute.
Competitive salary and benefits aligned with NIH guidelines.
Strong mentorship and support for professional development.
Company
Mount Sinai Health System
Mount Sinai Health System delivers integrated medical care, research, and medical education through its network.
H1B Sponsorship
Mount Sinai Health System has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (3)
2023 (26)
2022 (20)
2021 (6)
2020 (20)
Funding
Current Stage
Late StageTotal Funding
$41.9MKey Investors
National Institutes of HealthHearst Health Prize.Multiple Myeloma Research Foundation
2024-11-11Grant· $7M
2024-06-06Grant· $0.1M
2023-11-02Grant· $7M
Leadership Team
Recent News
Digital Journal
2026-01-08
Company data provided by crunchbase